PCOLE-1 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Human PCPE-1 (PCOLCE, UniProt Q15113) produced in HEK293 cells. Used in procollagen C-proteinase activity assays, BMP-1 enhancer studies, and antibody validation against the matched TPB antibody RP-PCOLE1.
Expression system
HEK293
Cat. #
REC-PCOLE1

In stock

SKU
REC-PCOLE1
$498.00

Target Overview

PCOLE-1 (Recombinant) is the human Procollagen C-endopeptidase enhancer 1 (PCPE-1), encoded by the PCOLCE gene (UniProt Q15113), produced by transient expression in HEK293 cells. The full-length human PCOLCE sequence spans 449 amino acids; the secreted mature form lacks the signal peptide and is recovered from conditioned medium under native-like glycosylation conditions that HEK293 expression affords — an important consideration for a secreted extracellular matrix (ECM) glycoprotein whose binding interactions are conformation-sensitive. PCPE-1 functions by binding to the C-terminal propeptide of fibrillar procollagens (most characterized for type I procollagen) and enhancing the proteolytic activity of procollagen C-proteinase (BMP-1/tolloid family metalloproteinases). It does not itself possess enzymatic activity; rather, it acts as a non-catalytic enhancer that accelerates the rate-limiting C-propeptide cleavage step of collagen maturation in the extracellular space. Researchers use this recombinant in several experimental contexts: (1) activity enhancement assays, where PCPE-1 is titrated alongside BMP-1 against a procollagen substrate to measure fold-increase in C-propeptide processing; (2) binding/interaction studies using surface plasmon resonance (SPR) or biolayer interferometry (BLI) to characterise affinity for procollagen C-propeptide; (3) inhibitor competition assays, where small-molecule or peptide inhibitors of the PCPE-1/BMP-1 axis are ranked by their ability to displace PCPE-1 from its substrate; and (4) antibody validation, where the recombinant serves as a positive control antigen alongside the matched Triple Point Biologics antibody (RP-PCOLE1), which has been validated for Western blot applications. HEK293-derived material is preferred over bacterial expression for this target because correct disulfide bonding within the CUB and NTR domains is required for functional activity.

Background

Procollagen C-endopeptidase enhancer 1 (PCPE-1, gene: PCOLCE) is a secreted glycoprotein of 449 amino acids that occupies a regulatory position in the fibrillar collagen biosynthesis pathway. It binds the C-terminal propeptide of type I procollagen and potentiates cleavage by BMP-1 (bone morphogenetic protein 1) and related astacin-family metalloproteinases collectively referred to as procollagen C-proteinases. The protein contains two CUB (complement/uEGF/BMP-1) domains responsible for procollagen propeptide recognition and a C-terminal NTR (netrin-related motif) domain. A close paralog, PCPE-2 (PCOLCE2), shares substantial sequence identity yet shows distinct tissue distribution and functional properties — a distinction examined in recent literature that highlights how sequence similarity between PCPE-1 and PCPE-2 can obscure their divergent biological roles (Sorci-Thomas MG et al., Arterioscler Thromb Vasc Biol, 2026; PMID 41953976). In basic collagen biology research, PCPE-1 is studied as a modulator of the rate and fidelity of type I collagen fibril assembly. Because excessive or dysregulated collagen deposition underlies fibrotic conditions across multiple organ systems, PCPE-1 has been investigated as a research target in fibrosis models. Studies of spinal cord injury have profiled PCPE-1 within the fibroblast-driven fibrous scar response, situating it among genes whose expression is altered in scar-forming cell populations characterised by single-cell sequencing (Zhang Z et al., Neural Regen Res, 2026; PMID 42199129). PCOLCE has also been identified in genomic and transcriptomic analyses of pelvic organ prolapse, a condition in which ECM remodelling and connective tissue integrity are central research questions. Beyond fibrosis and structural ECM biology, PCOLCE expression has emerged in tumor microenvironment profiling studies in gastric and bladder cancers, where stromal collagen remodelling genes are interrogated for their association with immune landscape features and patient outcomes. These observations position PCPE-1 as a research target at the intersection of ECM biology, stromal cell biology, and tumor microenvironment research — contexts in which a well-characterised recombinant standard with defined activity is a prerequisite for rigorous quantification and mechanistic dissection. Researchers requiring an antibody paired to this recombinant for Western blot positive controls or IHC standard-curve experiments should refer to the matched Triple Point Biologics antibody (SKU: RP-PCOLE1), validated for human PCPE-1 detection.

Applications

  • Procollagen C-proteinase enhancement assay: titration of PCPE-1 alongside BMP-1 against type I procollagen substrate to quantify fold-increase in C-propeptide cleavage
  • BMP-1/tolloid metalloproteinase inhibitor competition assay: ranking small-molecule or peptide inhibitors by displacement of PCPE-1 from procollagen C-propeptide
  • Surface plasmon resonance (SPR) or biolayer interferometry (BLI) binding kinetics: determination of KD for PCPE-1 interaction with procollagen C-propeptide
  • Antibody validation positive control: use as defined antigen in Western blot and IHC validation alongside matched antibody RP-PCOLE1
  • ELISA standard curve: recombinant PCPE-1 as calibrator for sandwich ELISA quantification of endogenous PCPE-1 in conditioned media or tissue lysates
  • Fibrosis model ECM assay: supplementing cell-free or cell-based collagen processing systems to assess PCPE-1 contribution to fibril assembly kinetics
  • PCPE-1 vs. PCPE-2 functional comparison: parallel assay format to distinguish enhancer activity and substrate selectivity between the two paralogs

References

  1. Sorci-Thomas MG et al. PCPE1 and PCPE2: When Sequence Similarity Masks Functional Diversity. Arterioscler Thromb Vasc Biol. 2026. doi:10.1161/ATVBAHA.126.324421. PMID: 41953976.
  2. Zhang Z et al. Dual role of fibroblasts in fibrous scar formation after spinal cord injury: Single-cell sequencing and experimental verification. Neural Regen Res. 2026. doi:10.4103/NRR.NRR-D-25-01445. PMID: 42199129.
  3. Liu X et al. Identification of Novel Disease-Modifying Agents for Pelvic Organ Prolapse by Systematic Druggable Genome-Wide Mendelian Randomization. Int J Womens Health. 2025. doi:10.2147/IJWH.S525908. PMID: 41089176.
  4. Huang W et al. Identification and single-cell analysis of prognostic genes related to mitochondrial and neutrophil extracellular traps in bladder cancer. Sci Rep. 2025. doi:10.1038/s41598-025-10413-3. PMID: 40615671.
  5. Liu L et al. Prognostic integration of tumor microenvironment and parthanatos-related genes in gastric cancer: a machine learning-driven risk model and immune landscape profiling. Front Immunol. 2026. doi:10.3389/fimmu.2026.1636331. PMID: 41798945.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Subcellular localization not yet annotated

Frequently Asked Questions

What is the expected molecular weight of PCOLE-1 (Recombinant) on SDS-PAGE and Western blot?

The full-length PCOLCE-encoded protein is 449 amino acids (predicted unglycosylated MW ~50 kDa), but because this recombinant is expressed in HEK293 cells under native-like glycosylation conditions, the observed band on reducing SDS-PAGE typically migrates at approximately 55–65 kDa. The shift reflects N-linked glycosylation characteristic of the secreted, mature ECM form. Expect a diffuse or slightly smeared band rather than a sharp single band — this is normal for glycoproteins and is not indicative of degradation. Deglycosylation with PNGase F collapses the band to ~50 kDa.

Is PCOLE-1 (Recombinant) the full-length protein or the mature secreted form lacking the signal peptide?

This recombinant corresponds to the mature secreted form of human PCPE-1 (UniProt Q15113). The N-terminal signal peptide is cleaved co-translationally during HEK293 expression, so what is recovered from conditioned medium is the processed extracellular form — the biologically relevant species for collagen maturation studies. No additional prodomain processing is required. The two CUB domains and the NTR domain are intact, preserving the conformation-sensitive binding interface with the C-terminal propeptide of fibrillar procollagens.

Does PCOLE-1 (Recombinant) have enzymatic activity itself, or does it require BMP-1/tolloid for collagen C-propeptide cleavage?

PCPE-1 is a non-catalytic enhancer — it has no intrinsic proteinase activity. Its function is to bind the C-terminal propeptide of fibrillar procollagens (best characterized for type I procollagen) and accelerate cleavage by BMP-1/tolloid family metalloproteinases. In activity assays, PCOLE-1 (Recombinant) should be used alongside a source of active BMP-1 or mTLD. Without the metalloproteinase, you will not observe substrate processing regardless of PCPE-1 concentration. This recombinant is validated as an enhancer, not a standalone proteinase.

What activity assay can I use to measure PCOLE-1 (Recombinant) enhancement of procollagen C-proteinase, and what substrate should I use?

The standard assay uses recombinant type I procollagen C-propeptide (pCP) or mini-procollagen substrates incubated with a titrated amount of active BMP-1 in the presence or absence of PCOLE-1 (Recombinant). Cleavage is monitored by SDS-PAGE densitometry or fluorescent-tagged substrate variants. A typical starting point is 50–200 ng/mL PCOLE-1 alongside 10–50 ng/mL BMP-1 in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂ at 37°C for 1–4 hours. Enhancement is expressed as fold-increase in cleavage rate relative to BMP-1 alone. Titrate PCPE-1 to establish dose-dependence before committing to a fixed concentration.

What buffer conditions are optimal for PCOLE-1 (Recombinant) activity assays and protein–protein interaction studies?

The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — is compatible with most collagen maturation assays and can be used directly. For SPR or pull-down binding assays measuring PCPE-1 interaction with procollagen C-propeptide, reduce glycerol to ≤1% by diluting into assay buffer immediately before use. CaCl₂ at 1–5 mM is recommended when BMP-1 is a binding partner, as it is required for metalloproteinase activity. Avoid EDTA or EGTA in functional assays. pH should remain between 7.2 and 7.8; PCPE-1 binding interactions are conformation-sensitive and activity drops sharply below pH 6.8.

What starting concentration of PCOLE-1 (Recombinant) is recommended for co-immunoprecipitation or pull-down with BMP-1?

For co-IP or GST/His-tag pull-down experiments, a practical starting range is 0.5–2 µg PCOLE-1 (Recombinant) per reaction. Because PCPE-1 binds the procollagen C-propeptide non-covalently with moderate affinity, keeping protein concentrations in the 100–500 nM range during incubation improves complex recovery. Include 0.05% Tween-20 and 1 mg/mL BSA in binding buffer to reduce non-specific adsorption. Verify the pulled-down PCPE-1 by Western blot using our matched antibody RP-PCOLE1, which is validated for WB and provides a reliable readout at these loading amounts.

Can I use PCOLE-1 (Recombinant) as a positive control for Western blot with the matched antibody RP-PCOLE1?

Yes — PCOLE-1 (Recombinant) and antibody RP-PCOLE1 are produced from the same lab and are guaranteed compatible for Western blot positive control applications. Load 25–100 ng of recombinant protein per lane on a 10–12% SDS-PAGE gel under reducing conditions. The antibody at 1:1,000–1:2,000 dilution (primary, overnight 4°C) detects a band at ~55–65 kDa, consistent with the glycosylated mature form. This serves as a reliable size marker and signal calibrator when running cell lysates or tissue extracts alongside. Product page and protocol for RP-PCOLE1 are at /anti-pcole-1-rabbit-polyclonal-antibody.

How should I handle, dilute, and store PCOLE-1 (Recombinant) to maintain activity over multiple experiments?

PCOLE-1 (Recombinant) is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol as single-use aliquots. Store at -20°C; purity is >95% by SDS-PAGE and endotoxin is <0.1 EU/µg by LAL. Avoid repeated freeze-thaw — each cycle risks glycoprotein aggregation and loss of the native conformation required for procollagen C-propeptide binding. For working dilutions, prepare fresh in assay buffer the day of the experiment and keep on ice. If you anticipate multiple uses within a week, a single thaw followed by storage at 4°C for up to 5 days is acceptable; beyond that, re-aliquot before first thaw.

Validation imagery coming soon

Western blot validation figures for REC-PCOLE1 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →